BARCELONA—For children with intracranial ependymoma and measurable residue after first- or second-line surgery, a hypofractionated radiotherapy boost was feasible and improved local control—in a study presented to the 3rd ESTRO Forum. Lead author Lorenza Gandola MD, from Istituto Nazionale dei Tumori in Milan, explained to Oncology Times reporter Sarah Maxwell how they found that increasing the dose of radiotherapy significantly improved survival.
You may also like...
Global Handwashing Day: Faecal Bacteria Found On Mobile Phones 12 Nov, 2011
Growing Evidence that Anti BRAF Melanoma Drugs Benefit Some Patients with Non-Small Cell Lung Cancer 27 Apr, 2015
Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia 6 Aug, 2013
Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer 11 Feb, 2014
- Previous story Accelerated Partial Breast Irradiation for Women over 70 with Early Breast Cancer Improved Outcomes
- Next story Higher Radiation Dose Improved Survival in Children with Ependymoma
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014
- First enterovirus 71 vaccines effective against hand, foot and mouth diseaseFebruary 28, 2014